NOV. 11, 2026. Advancing dyslipidemia management through lifestyle intervention – plant sterols as a CCS-recommended strategy for LDL-C lowering
Your speaker
John L. Sievenpiper, MD, PhD, FRCPC
Member of the CCS Dyslipidemia Guideline Committee
Diabetes Canada Clinician Scientist
Professor, Departments of Nutritional Sciences and Medicine, University of Toronto
Staff Physician, Division of Endocrinology & Metabolism, St. Michael’s Hospital
Scientist, Li Ka Shing Knowledge Institute, St. Michael’s Hospital
Nutrition Theme Lead, MD Program, University of Toronto
Learning objectives
By the end of this presentation, participants will be able to:
Review the fundamental principles of non-pharmacological management of dyslipidemia, including dietary approaches, physical activity, tobacco use, e-cigarettes, cannabis, and coffee consumption.
Integrate these evidence-based lifestyle interventions into the overall care and cardiovascular risk management of patients with dyslipidemia.
Determine which patients in primary and secondary prevention may achieve further LDL-C reduction and cardiovascular risk improvement through targeted lifestyle changes.
Non-accredited
1 hour (60 minutes)
